Skip to content

The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder

The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02542709
Enrollment
28
Registered
2015-09-07
Start date
2015-03-31
Completion date
2016-03-31
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic Stress Disorder

Brief summary

The purpose of this trial is to study the effect of noninvasive brain stimulation in adults with post-traumatic stress disorder.

Detailed description

The purpose of this trial is to study the effect of noninvasive brain stimulation on symptoms severity in adults with post-traumatic stress disorder.

Interventions

Active transcranial magnetic stimulation will induce real pulses using the transcranial magnetic stimulation device.

DEVICESham repetitive Transcranial Magnetic Stimulation

Sham transcranial magnetic stimulation will not induce any pulses using the same transcranial magnetic stimulation device but by also adding a sham block device.

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-60 years old

Exclusion criteria

* Transcranial magnetic stimulation ineligibility

Design outcomes

Primary

MeasureTime frameDescription
Severity of symptoms on the following clinical scale: PTSD symptoms as assessed by the Modified PTSD Symptom Scale (MPSS-SR)2 monthsUnits will be the differences (%) in scores before and after the intervention

Secondary

MeasureTime frameDescription
Severity of symptoms on the following clinical scale: anxiety symptoms as assessed by the Beck Anxiety Inventory (BAI)2 monthsUnits will be the differences (%) in scores before and after the intervention
Severity of symptoms on the following clinical scale: depression symptoms as assessed by the Beck Depression Inventory (BDI)2 monthsUnits will be the differences (%) in scores before and after the intervention

Countries

Canada

Contacts

Primary ContactJean Levasseur-Moreau
jean.levasseur-moreau.1@ulaval.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026